• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定并描述一个导致部分性肾性尿崩症的新型 X 连锁 AVP2R 基因突变:病例报告及文献复习。

Identification and characterization of a novel X-linked AVPR2 mutation causing partial nephrogenic diabetes insipidus: a case report and review of the literature.

机构信息

Department of Molecular Genetics, Function and Therapy, The Cyprus Institute of Neurology and Genetics, P.O. Box 23462, 1683 Nicosia, Cyprus.

出版信息

Metabolism. 2012 Jul;61(7):922-30. doi: 10.1016/j.metabol.2012.01.005. Epub 2012 Mar 3.

DOI:10.1016/j.metabol.2012.01.005
PMID:22386940
Abstract

X-linked nephrogenic diabetes insipidus (NDI) is a rare disease characterized by a malfunctioning renal response to the antidiuretic hormone arginine vasopressin (AVP) due to mutations in the AVPR2 gene. A limited number of mutations in the AVPR2 gene resulting in partial phenotype have been described so far. In this mini-review the retrospective analysis of 13 known AVPR2 mutations that have been previously shown in vitro to partially abolish AVPR2 function is described, along with a novel mutation diagnosed in a kindred with partial NDI. In the present study, a 14 year old male and his 73 year old maternal grandfather were diagnosed with partial NDI based on the clinical phenotype, the water deprivation test and the inadequate response to 1-desamino-8-d-arginine vasopressin (DDAVP) administration. Sequencing analysis of the AVPR2 gene revealed the novel missense mutation p.N317S (g.1417A > G) in both patients. This mutation was re-created by site directed mutagenesis in an AVPR2 cDNA expression vector and was functionally characterized, in terms of arginine vasopressin (AVP) and DDAVP response. AVPR2 activity of the p.N317S mutant receptor after the AVP and DDAVP administration, as assessed by cAMP production was reduced and impaired when compared to cells that expressed the wild type AVPR2 gene. In conclusion, the affected members of this family have X-linked NDI with partial resistance to AVP, due to a missense mutation in the AVPR2 gene.

摘要

X 连锁遗传性肾性尿崩症(NDI)是一种罕见疾病,其特征为抗利尿激素精氨酸加压素(AVP)的肾脏反应失常,这是由于 AVPR2 基因突变所致。迄今为止,已有少数导致部分表型的 AVPR2 基因突变被描述。在本篇迷你综述中,我们对之前已在体外证实部分丧失 AVPR2 功能的 13 种已知 AVPR2 突变进行了回顾性分析,并描述了在一个具有部分 NDI 的家族中诊断出的一种新突变。在本研究中,一名 14 岁男性及其 73 岁的外祖父根据临床表型、禁水试验和 1-脱氨-8-D-精氨酸加压素(DDAVP)给药后的反应不足,被诊断为患有部分 NDI。AVPR2 基因测序分析显示,这两名患者均存在新的错义突变 p.N317S(g.1417A > G)。该突变在 AVPR2 cDNA 表达载体中通过定点诱变重新构建,并在功能上进行了表征,包括对 AVP 和 DDAVP 的反应。与表达野生型 AVPR2 基因的细胞相比,p.N317S 突变受体在给予 AVP 和 DDAVP 后,AVP 和 DDAVP 反应的 AVPR2 活性降低且受损。总之,这个家族的受影响成员患有 X 连锁遗传性 NDI,对 AVP 具有部分抗性,这是由于 AVPR2 基因中的错义突变所致。

相似文献

1
Identification and characterization of a novel X-linked AVPR2 mutation causing partial nephrogenic diabetes insipidus: a case report and review of the literature.鉴定并描述一个导致部分性肾性尿崩症的新型 X 连锁 AVP2R 基因突变:病例报告及文献复习。
Metabolism. 2012 Jul;61(7):922-30. doi: 10.1016/j.metabol.2012.01.005. Epub 2012 Mar 3.
2
Partial nephrogenic diabetes insipidus caused by a novel mutation in the AVPR2 gene.由AVPR2基因新突变引起的部分性肾性尿崩症。
Clin Endocrinol (Oxf). 2008 Mar;68(3):395-403. doi: 10.1111/j.1365-2265.2007.03054.x. Epub 2007 Oct 17.
3
AVPR2 variants and mutations in nephrogenic diabetes insipidus: review and missense mutation significance.肾性尿崩症中的精氨酸加压素受体2(AVPR2)变体与突变:综述及错义突变的意义
J Cell Physiol. 2008 Dec;217(3):605-17. doi: 10.1002/jcp.21552.
4
Vasopressin receptor mutations causing nephrogenic diabetes insipidus.导致肾性尿崩症的血管加压素受体突变。
Proc Assoc Am Physicians. 1998 Sep-Oct;110(5):387-94.
5
[Identification of mutations in the arginine vasopressin receptor 2 gene in congenital nephrogenic diabetes insipidus patients].[先天性肾性尿崩症患者精氨酸加压素受体2基因突变的鉴定]
Zhonghua Yi Xue Za Zhi. 2002 Oct 25;82(20):1401-5.
6
Functional characterization of vasopressin receptor 2 mutations causing partial and complete congenital nephrogenic diabetes insipidus in Thai families.功能性鉴定导致部分性和完全性先天性肾性尿崩症的血管加压素受体 2 突变在泰国家庭中的作用。
Horm Res Paediatr. 2010;73(5):349-54. doi: 10.1159/000308167. Epub 2010 Apr 14.
7
A novel AVPR2 splice site mutation leads to partial X-linked nephrogenic diabetes insipidus in two brothers.一种新的AVPR2剪接位点突变导致两兄弟患部分性X连锁肾性尿崩症。
Eur J Pediatr. 2016 May;175(5):727-33. doi: 10.1007/s00431-015-2684-4. Epub 2016 Jan 21.
8
Functional characterization of novel loss-of-function mutations in the vasopressin type 2 receptor gene causing nephrogenic diabetes insipidus.血管加压素 2 型受体基因中引起肾性尿崩症的新型功能丧失突变的功能特征。
Nephrol Dial Transplant. 2012 Apr;27(4):1521-8. doi: 10.1093/ndt/gfr487. Epub 2011 Sep 13.
9
Identification of mutations in the arginine vasopressin receptor 2 gene causing nephrogenic diabetes insipidus in Chinese patients.中国患者中导致肾性尿崩症的精氨酸加压素受体2基因突变的鉴定。
J Hum Genet. 2002;47(2):66-73. doi: 10.1007/s100380200002.
10
Vasopressin type 2 receptor V88M mutation: molecular basis of partial and complete nephrogenic diabetes insipidus.血管加压素 2 型受体 V88M 突变:部分和完全肾性尿崩症的分子基础。
Nephron Physiol. 2010;114(1):p1-10. doi: 10.1159/000245059. Epub 2009 Oct 8.

引用本文的文献

1
Therapeutic potentials of nonpeptidic V2R agonists for partial cNDI-causing V2R mutants.非肽类 V2R 激动剂治疗部分 cNDI 致病 V2R 突变体的潜力。
PLoS One. 2024 May 15;19(5):e0303507. doi: 10.1371/journal.pone.0303507. eCollection 2024.
2
Three Pediatric Patients with Congenital Nephrogenic Diabetes Insipidus due to Nonsense Mutations and Different Clinical Manifestations: A Case Report.3例因无义突变导致先天性肾性尿崩症的儿科患者及不同临床表现:病例报告
Case Rep Nephrol Dial. 2023 Oct 18;13(1):162-172. doi: 10.1159/000533895. eCollection 2023 Jan-Dec.
3
Pro-haemostatic effect of DDAVP is partially derived through non-classical (CD14 /CD16 ) monocytes residing the spleen.
DDAVP 的促凝作用部分来源于脾脏中存在的非经典(CD14/CD16)单核细胞。
J Cell Mol Med. 2023 Jan;27(1):30-35. doi: 10.1111/jcmm.17606. Epub 2022 Dec 7.
4
Oral disintegrating desmopressin tablet is effective for partial congenital nephrogenic diabetes insipidus with mutation: a case report.口腔崩解去氨加压素片对部分伴有突变的先天性肾性尿崩症有效:一例报告
Clin Pediatr Endocrinol. 2022;31(2):87-92. doi: 10.1297/cpe.2021-0032. Epub 2022 Feb 18.
5
Partial nephrogenic diabetes insipidus with a novel arginine vasopressin receptor 2 gene variant.伴有新型精氨酸加压素受体2基因突变的部分性肾性尿崩症
Clin Pediatr Endocrinol. 2022;31(1):44-49. doi: 10.1297/cpe.2021-0029. Epub 2021 Nov 1.
6
Prediction of molecular interactions and physicochemical properties relevant for vasopressin V2 receptor antagonism.预测与血管加压素 V2 受体拮抗作用相关的分子相互作用和物理化学性质。
J Mol Model. 2022 Jan 7;28(2):31. doi: 10.1007/s00894-021-05022-6.
7
Functional characterization of a loss-of-function mutant I324M of arginine vasopressin receptor 2 in X-linked nephrogenic diabetes insipidus.I324M 缺失功能突变的精氨酸血管加压素受体 2 对 X 连锁性肾性尿崩症的功能特征分析。
Sci Rep. 2021 May 26;11(1):11057. doi: 10.1038/s41598-021-90736-z.
8
Identification of a novel X-linked arginine-vasopressin receptor 2 mutation in nephrogenic diabetes insipidus: Case report and pedigree analysis.肾性尿崩症中一种新的X连锁精氨酸加压素受体2突变的鉴定:病例报告及家系分析
Medicine (Baltimore). 2019 Oct;98(40):e17359. doi: 10.1097/MD.0000000000017359.
9
A novel AVPR2 missense mutation in an Asian family with inherited nephrogenic diabetes insipidus: A case report.一个患有遗传性肾性尿崩症的亚洲家族中的新型AVPR2错义突变:病例报告。
Medicine (Baltimore). 2019 Apr;98(17):e15348. doi: 10.1097/MD.0000000000015348.
10
Four Japanese Patients with Congenital Nephrogenic Diabetes Insipidus due to the Mutations.四名因该突变导致先天性肾性尿崩症的日本患者。
Case Rep Pediatr. 2018 Jul 3;2018:6561952. doi: 10.1155/2018/6561952. eCollection 2018.